Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹60 Cr₹58 Cr₹46 Cr₹58 Cr₹96 Cr

What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?

The latest Total Non-Current Liabilities ratio of VENUS REMEDIES is ₹60 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹46 Cr
Mar2021₹58 Cr
Mar2020₹96 Cr

How is Total Non-Current Liabilities of VENUS REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹60 Cr
2.89
Mar2023 ₹58 Cr
26.60
Mar2022 ₹46 Cr
-20.94
Mar2021 ₹58 Cr
-39.34
Mar2020 ₹96 Cr -

Compare Total Non-Current Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹410.9 Cr 5.3% -10.7% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,478.0 Cr -1.3% -4.8% 45% Stock Analytics
DIVIS LABORATORIES ₹163,822.0 Cr 0.5% 6.4% 58.2% Stock Analytics
CIPLA ₹123,920.0 Cr 2.1% 3.8% 24.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,322.0 Cr -0.6% -5.7% 5.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,217.3 Cr 0.1% -3.6% 48.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

5.3%

-10.7%

-19.6%

SENSEX

0.9%

-0.3%

20.9%


You may also like the below Video Courses